908 Devices Inc. (NASDAQ:MASS) Shares Bought by 49 Wealth Management LLC

49 Wealth Management LLC lifted its holdings in shares of 908 Devices Inc. (NASDAQ:MASS) by 16.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,099 shares of the company’s stock after acquiring an additional 4,343 shares during the period. 49 Wealth Management LLC owned 0.09% of 908 Devices worth $108,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in MASS. State Board of Administration of Florida Retirement System acquired a new stake in shares of 908 Devices during the 1st quarter worth about $80,000. Vanguard Group Inc. raised its position in shares of 908 Devices by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 1,751,102 shares of the company’s stock worth $13,221,000 after acquiring an additional 6,772 shares in the last quarter. AWM Investment Company Inc. raised its position in shares of 908 Devices by 2.3% during the 1st quarter. AWM Investment Company Inc. now owns 668,526 shares of the company’s stock worth $5,047,000 after acquiring an additional 15,058 shares in the last quarter. GAMMA Investing LLC acquired a new stake in shares of 908 Devices during the 2nd quarter worth about $48,000. Finally, Bank of New York Mellon Corp raised its position in shares of 908 Devices by 6.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 69,550 shares of the company’s stock worth $358,000 after acquiring an additional 4,212 shares in the last quarter. Institutional investors and hedge funds own 88.06% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on MASS shares. Leerink Partners reissued a “market perform” rating and set a $4.00 target price (down previously from $12.00) on shares of 908 Devices in a research report on Wednesday, November 13th. Leerink Partnrs downgraded 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Finally, Stifel Nicolaus dropped their price target on 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th.

908 Devices Stock Performance

NASDAQ:MASS opened at $2.56 on Friday. The stock’s 50 day moving average price is $3.32 and its 200 day moving average price is $4.55. 908 Devices Inc. has a 52-week low of $2.19 and a 52-week high of $12.51.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.